StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Synergy Pharma (SGYP): Results Show Trulance Accelerating - HC Wainwright
March 5, 2018 7:51 AM
H.C. Wainwright analyst, reiterated his Buy rating on shares of Synergy Pharmaceuticals (NASDAQ: SGYP) after the company reported topline revenue ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst EPS Change
Analyst EPS View
Next Articles
Synergy Pharmaceuticals (SGYP) PT Lowered to $8 at Cantor Fitzgerald, Keeps 'Overweight'
March 6, 2018 11:05 AM